While immune cells were traditionally considered to eliminate tumor cells more specifically and effectively compared to chemotherapy agents, a recent study indicated that IFN-γ produced by T cells enhanced a cancer stem cell signature in cancer patients treated with ICB therapy [19]. Here, IFNG is linked to cancer.